Language

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.   

Select Language

Tina Roy, MD

Portrait of Tina Roy, MD

Tina Roy, MD, is a hematologist-oncologist who provides comprehensive care for patients with cancer and blood disorders. She has a particular clinical interest in lung cancer and the use of targeted therapies, immunotherapy, and other personalized treatment approaches. Dr. Roy completed her fellowship training in Hematology and Oncology at MedStar Georgetown University Hospital. Before fellowship, […]

Ellery Altshuler, MD

Portrait of Ellery Altshuler, MD

Ellery Altshuler, MD completed fellowship training in Hematology and Medical Oncology at Johns Hopkins Medicine after earning his medical degree and completing his residency in Internal Medicine at the University of Florida College of Medicine. Dr. Altshuler has contributed to academic and research initiatives focused on clinical trials, most recently on KRAS inhibitor studies across […]

Thoracic / Lung

Address Lung Cancer – Advance Early Detection, Understand Risk Factors, And Access Innovative Treatments For Respiratory Health

Thoracic / Lung Cancer This section will cover non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma. A diagnosis of lung cancer can feel overwhelming, but understanding the disease, how it is diagnosed, and the treatment options available can help you make informed decisions about your care. Advances in cancer treatment, including […]

Christopher R. Johnson, MD

Portrait of Christopher R. Johnson, MD

Dr. Christopher R. Johnson is board certified in general surgery and has completed fellowship training in thoracic surgery. In 2025, he joined Virginia Cancer Specialists with over a decade of clinical and research experience. He has a special interest in robotic thoracic surgery, lung cancer care, and minimally invasive surgical techniques. Dr. Johnson earned his […]

Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer

3d rendered medically accurate illustration of lung cancer

Living with advanced non–small cell lung cancer (NSCLC) driven by mutations in the EGFR gene can feel overwhelming. For many patients, treatment has meant targeted therapy with the gold standard osimertinib, an oral targeted therapy directed toward the EGFR mutated tumor cells.  Data from the large MARIPOSA trial published in September 2025 in The New […]

Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD

Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer

Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]